Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide for Opioid-Induced Constipation
NCT02270983Phase 2Completed
- Sponsor
- Forest Laboratories
- Start
- Oct 2014
- Primary completion
- Aug 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of linaclotide in opioid-induced constipation (OIC), sponsored by Forest Laboratories. Started Oct 2014; status: completed.
02
Drugs
linaclotide
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT02270983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02270983.